Neurology  


A Study of Tadalafil for Duchenne Muscular Dystrophy   
Principal Investigator (Site):  Nancy L. Kuntz, MD 
Phone:  312-227-4483  
Contact:  Lauren Webb, Research Coordinator 
Email:  Lwebb@luriechildrens.org 
ClinicalTrials.gov Identifier:  NCT 01865084 (IRB #2013-15483) 

The Effect of Ankle Foot Orthoses on Attention Demands  during Gait in Children with Myelomeningocele
Principal Investigator:  Nikta Pirouz
Contact Phone:  312-227-6210
Email:  NPirouz@luriechildrens.org
IRB Number:  2012-14865

Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Principal Investigator: Nancy L. Kuntz, MD
Phone: 312.227.4483
Email: lwebb@luriechildrens.org
ClinicalTrials.gov Identifier NCT 01736553;  IRB #: 2013-15165 
        Recruitment Brochure

Duchenne muscular dystrophy: double-blind randomized trial to find optimum steroid regimen
Principal Investigator: Nancy L. Kuntz, MD
Phone: 312.227.4483
Email: lwebb@luriechildrens.org
ClinicalTrials.gov Identifier NCT 01603407; IRB #2013-15229

Natural History of Clinical, Biochemical, Pathologic and Genetic Markers in Children with Neuromuscular Weakness 
Principal Investigator: Nancy L. Kuntz, MD
Phone: 312.227.4483
Email: lwebb@luriechildrens.org
IRB# 2011-14701

Cardiac and Autonomic Nervous System Dysregualtion (ANSD) in Spinal Muscular Atrophy
Principal Investigator: Nancy L. Kuntz, MD
Phone: 312.227.4483
Email: lwebb@luriechildrens.org
IRB #2011-14624

Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies
Principal Investigator: Nancy L. Kuntz, MD
Phone: 312.227.4483
Email: lwebb@luriechildrens.org
ClinicalTrials.gov Identifier NCT01126697; IRB #2010-14247

A multicenter collaborative study on the clinical features, expression profiling, and quality of life of infantile onset facioscapulohumeral muscular dystrophy Principal Investigator: Nancy L. Kuntz, MD
Phone: 312.227.4483
Email: lwebb@luriechildrens.org
ClinicalTrials.gov Identifier NCT01437345; IRB #2013-15336

Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping
Principal Investigator: Nancy L. Kuntz, MD
Phone: 312.227.4483
Email: lwebb@luriechildrens.org
ClinicalTrials.gov Identifier NCT01539772; IRB #2013-15332

Longitudinal Study of the Relationship between Impairment, Activity Limitation, Participation and Quality of Life in Persons with Confirmed Duchenne Muscular Dystrophy (DMD) Principal Investigator: Nancy L. Kuntz, MD
Phone: 312.227.4483
Email: lwebb@luriechildrens.org
ClinicalTrials.gov Identifier NCT00468832; IRB #2013-15337

Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis Principal Investigator: Jennifer Rubin, MD
Phone: 312.227.4483
Email: lwebb@luriechildrens.org
ClinicalTrials.gov Identifier NCT01396343; IRB# 2012-14997

Pediatric Multiple Sclerosis and Other Demyelinating Diseases (PeMSDD)
Principal Investigator: Jennifer Rubin, MD
Phone: 312.227.4483
Email: lwebb@luriechildrens.org
IRB #: 2012-14997